Last update 04 Nov 2024
Jiangsu Aosaikang Biomedicine Co., Ltd.
Private Company|
2016|
Jiangsu Sheng, China
Last update 04 Nov 2024
Overview
Tags
Neoplasms
Digestive System Disorders
Fusion protein
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
注射用ASKG915单药治疗在晚期实体瘤患者中安全性、耐受性及药代动力学的Ⅰ期临床研究
[Translation] Phase I clinical study on the safety, tolerability and pharmacokinetics of ASKG915 monotherapy for injection in patients with advanced solid tumors
评价ASKB589注射液或安慰剂联合CAPOX（奥沙利铂和卡培他滨）及PD-1抑制剂一线治疗CLDN18.2 阳性的不可切除的局部晚期、复发性或转移性胃及食管胃交界处腺癌患者的有效性和安全性的III期临床研究
[Translation] A phase III clinical study to evaluate the efficacy and safety of ASKB589 injection or placebo combined with CAPOX (oxaliplatin and capecitabine) and PD-1 inhibitors as first-line treatment for patients with CLDN18.2-positive unresectable locally advanced, recurrent or metastatic gastric and esophagogastric junction adenocarcinoma
ASKB589注射液联合CAPOX（奥沙利铂及卡培他滨）及信迪利单抗在一线治疗局部晚期、复发性或转移性胃及食管胃交界处腺癌患者中安全性、耐受性、药代动力学及抗肿瘤活性的Ⅰb/Ⅱ期临床研究
[Translation] A phase Ib/II clinical study on the safety, tolerability, pharmacokinetics and antitumor activity of ASKB589 injection combined with CAPOX (oxaliplatin and capecitabine) and sintilimab in the first-line treatment of patients with locally advanced, recurrent or metastatic gastric and esophagogastric junction adenocarcinoma
100 Clinical Results associated with Jiangsu Aosaikang Biomedicine Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Jiangsu Aosaikang Biomedicine Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Aosaikang Biomedicine Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 01 Dec 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
2
1
Phase 3
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free